SCHEMBL1206970

SCHEMBL1206970

Cc1cc(S(=O)(=O)O)cnc1Cl.NC(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 6/20 0.45
FLT4 P35916 6/20 0.45
KDR P35968 6/20 0.45
GABRA1 P14867 3/20 0.40
GABRG2 P18507 3/20 0.40
GABRB3 P28472 3/20 0.40
GABRB2 P47870 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
USP2 O75604 1/20 0.39
ALOX15 P16050 1/20 0.39
AVPR2 P30518 1/20 0.39
GPR27 Q9NS67 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 2/20 0.39
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4374098 0.85 ALDH1A1 (0.46) FLT1FLT4KDRMEN1KMT2A
SCHEMBL1207427 0.82 FLT1 (0.44) FLT1FLT4KDRPOLBMEN1
SCHEMBL4373446 0.82 ALDH1A1 (0.42) FLT1FLT4KDRL3MBTL1KMT2A
SCHEMBL1206967 0.79 FLT1 (0.66) FLT1FLT4KDR
SCHEMBL1207421 0.79 MAP2 (0.42) FLT1FLT4KDRPOLBMEN1
SCHEMBL4371552 0.78 ALDH1A1 (0.43) FLT1FLT4KDRL3MBTL1KMT2A
SCHEMBL4373108 0.76 MKNK1 (0.56) FLT1FLT4KDRPOLBMEN1
SCHEMBL4370293 0.75 KMT2A (0.47) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL4371954 0.75 ALDH1A1 (0.46) FLT1FLT4KDRKMT2AALDH1A1
SCHEMBL4372928 0.75 FLT1 (0.43) FLT1FLT4KDRL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879884-B2 6-(2-Chloro-phenyl)-5-methyl-pyridine-3-sulfonic acid 2-chloro-4-fluoro-benzoylamide; potassium salt, used as antiproliferative, anticarcinogenic or antitumor agents HOFFMANN-LA ROCHE INC. (US) 2011-02-01 US disclosed
US-20100256200-A1 ARYL PYRIDYL SULFONAMIDE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256200-A1 ARYL PYRIDYL SULFONAMIDE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS ARSA, STS, SULT2A1 FLT1 2946/4885FLT4 3444/4885KDR 3774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.